Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Deficiency of histone lysine methyltransferase SETDB2 in hematopoietic cells promotes vascular inflammation and accelerates atherosclerosis
Xinbo Zhang, Jonathan Sun, Alberto Canfrán-Duque, Binod Aryal, George Tellides, Ying Ju Chang, Yajaira Suárez, Timothy F. Osborne, Carlos Fernández-Hernando
Xinbo Zhang, Jonathan Sun, Alberto Canfrán-Duque, Binod Aryal, George Tellides, Ying Ju Chang, Yajaira Suárez, Timothy F. Osborne, Carlos Fernández-Hernando
View: Text | PDF
Research Article Inflammation Vascular biology

Deficiency of histone lysine methyltransferase SETDB2 in hematopoietic cells promotes vascular inflammation and accelerates atherosclerosis

  • Text
  • PDF
Abstract

Epigenetic modifications of the genome, including DNA methylation, histone methylation/acetylation, and noncoding RNAs, have been reported to play a fundamental role in regulating immune response during the progression of atherosclerosis. SETDB2 is a member of the KMT1 family of lysine methyltransferases, and members of this family typically methylate histone H3 Lys9 (H3K9), an epigenetic mark associated with gene silencing. Previous studies have shown that SETDB2 is involved in innate and adaptive immunity, the proinflammatory response, and hepatic lipid metabolism. Here, we report that expression of SETDB2 is markedly upregulated in human and murine atherosclerotic lesions. Upregulation of SETDB2 was observed in proinflammatory M1 but not antiinflammatory M2 macrophages. Notably, we found that genetic deletion of SETDB2 in hematopoietic cells promoted vascular inflammation and enhanced the progression of atherosclerosis in BM transfer studies in Ldlr-knockout mice. Single-cell RNA-Seq analysis in isolated CD45+ cells from atherosclerotic plaques from mice transplanted with SETDB2-deficient BM revealed a significant increase in monocyte population and enhanced expression of genes involved in inflammation and myeloid cell recruitment. Additionally, we found that loss of SETDB2 in hematopoietic cells was associated with macrophage accumulation in atherosclerotic lesions and attenuated efferocytosis. Overall, these studies identify SETDB2 as an important inflammatory cell regulator that controls macrophage activation in atherosclerotic plaques.

Authors

Xinbo Zhang, Jonathan Sun, Alberto Canfrán-Duque, Binod Aryal, George Tellides, Ying Ju Chang, Yajaira Suárez, Timothy F. Osborne, Carlos Fernández-Hernando

×

Figure 3

Loss of SETDB2 in hematopoietic cells promotes atherosclerosis progression and plaque instability.

Options: View larger image (or click on image) Download as PowerPoint
Loss of SETDB2 in hematopoietic cells promotes atherosclerosis progressi...
(A) Representative histological analysis of cross-sections of the aortic sinus stained with H&E (left) and Masson’s trichrome (right) in Ldlr–/– mice transplanted with WT or Setdb2GT BM fed a Western diet for 14 weeks. Means of the lesion area, necrotic core (NC) area, and fibrous cap (FC) thickness calculated from H&E-stained and Masson’s trichrome–stained aortic cross-sections were quantified and are shown (n = 8–10 mice per group). Dashed lines indicate the atherosclerotic lesion, and continuous lines indicate the boundary of the developing NC (plaque acellular area). (B and C) Representative immunofluorescence analysis of aortic root cross-sections of the aortic root lesions stained with CD68 (macrophage marker) and smooth muscle α-actin (α-SMA) (B) as well as NOS2 and VCAM-1 (C) in Ldlr–/– mice transplanted with WT or Setdb2GT BM fed a Western diet for 14 weeks. Dashed lines indicate the atherosclerotic lesion. Quantifications are shown (n = 8–10 mice per group). All data represent mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 compared with Ldlr–/– mice transplanted with WT BM. Data were analyzed by an unpaired 2-tailed Student’s t test. Scale bar: 100 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts